These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11923680)

  • 1. The preclinical model of choice.
    Thomas FT; Thomas JM
    Transplantation; 2002 Mar; 73(6):839. PubMed ID: 11923680
    [No Abstract]   [Full Text] [Related]  

  • 2. [Presensitization of donor splenic dendritic cells with the CD40/CD40L blockade induce long-term graft acceptance].
    Usuki T
    Hokkaido Igaku Zasshi; 2002 Nov; 77(6):571-9. PubMed ID: 12491629
    [No Abstract]   [Full Text] [Related]  

  • 3. Blockade of CD154-CD40 pathway induces interleukin-10 dependent T regulatory type 1 like cells.
    Cai Y; Yang YR; Xia P; Zheng SL
    Chin Med J (Engl); 2006 Mar; 119(6):518-22. PubMed ID: 16584652
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene transfer of human CD40Ig does not prevent rejection in a non-human primate kidney allotransplantation model.
    Angin M; Poirier N; Dilek N; Le Guiner C; Toromanoff A; Blancher A; Cherel Y; Deschamps JY; Tillou X; Renaudin K; Minault D; Hervouet J; Blancho G; Vanhove B; Anegon I; Le Mauff B
    Transpl Immunol; 2012 Dec; 27(4):139-45. PubMed ID: 23098770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac allograft acceptance induced by blockade of CD40-CD40L costimulation is dependent on CD4+CD25+ regulatory T cells.
    Jiang X; Sun W; Guo D; Cui Z; Zhu L; Lin L; Tang Y; Wang X; Liang J
    Surgery; 2011 Mar; 149(3):336-46. PubMed ID: 20875655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific transfusion in living related and unrelated donor kidney transplantation: minimal sensitization and excellent graft outcome.
    Kong JM; Jeong JH; Kang JK; Seong IG; Kim BC
    Transplant Proc; 1995 Feb; 27(1):1036-7. PubMed ID: 7878792
    [No Abstract]   [Full Text] [Related]  

  • 7. Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation.
    Alexander JW; Davies CB; First MR; Cofer BR; Munda R; Madden RL; Hariharan S; Schroeder TJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):485-7. PubMed ID: 8438389
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of allograft survival by single intraoperative donor-specific blood transfusion combined with FK506.
    Fabrega AJ; Blanchard JM; Rivas PA; Pollak R
    Transplantation; 1993 Dec; 56(6):1579-80. PubMed ID: 7506458
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of donor-specific blood transfusions on graft outcome in live donor renal transplantations.
    Velidedeoğlu E; Tokyay R; Haberal M
    Transplant Proc; 1992 Dec; 24(6):2752-3. PubMed ID: 1465927
    [No Abstract]   [Full Text] [Related]  

  • 10. Beneficial effects of double-filtration plasmapheresis on living related donor renal transplantation in presensitized recipients.
    Miura S; Okazaki H; Sato T; Amada N; Terashima T
    Transplant Proc; 1995 Feb; 27(1):1040-1. PubMed ID: 7878794
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-idiotypic autoantibodies after donor-specific blood transfusions.
    Toma H; Hayasaka Y; Yasuo M; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1987 Feb; 19(1 Pt 1):755-7. PubMed ID: 3274864
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.
    Haanstra KG; Ringers J; Sick EA; Ramdien-Murli S; Kuhn EM; Boon L; Jonker M
    Transplantation; 2003 Mar; 75(5):637-43. PubMed ID: 12640302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of pretransplant blood transfusions.
    Solheim BG
    Transplant Proc; 1979 Mar; 11(1):138-44. PubMed ID: 109960
    [No Abstract]   [Full Text] [Related]  

  • 14. Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin.
    Mourad G; Cristol JP; Chong G; Lorho R; Argiles A; Seignalet J; Mion C
    Transplant Proc; 1992 Dec; 24(6):2512-3. PubMed ID: 1465849
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired kidney graft survival in flow cytometric crossmatched positive donor-specific transfusion recipients.
    Bou-Habib JC; Krams S; Colombe BW; Lou C; Bubar OT; Yousif B; Amend WJ; Salvatierra O; Melzer J; Garovoy MR
    Transplant Proc; 1991 Feb; 23(1 Pt 1):403-4. PubMed ID: 1990566
    [No Abstract]   [Full Text] [Related]  

  • 16. CD40/CD40L signaling and its implication in health and disease.
    Chatzigeorgiou A; Lyberi M; Chatzilymperis G; Nezos A; Kamper E
    Biofactors; 2009; 35(6):474-83. PubMed ID: 19904719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor specific blood transfusions do not improve graft survival in living related donor transplantation.
    Garcia VD; Kraemer ES; Prompt CA; Santos A; Caovila J; Duarte A; Filho AN; Goldani JC
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2271-3. PubMed ID: 3274507
    [No Abstract]   [Full Text] [Related]  

  • 18. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
    Cai Y; Zhou PJ; Tang XD
    Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-specific transfusion for kidney transplantation in the cyclosporine era.
    Inoue S; Aikawa M; Dobashi Y; Kuzuhara K; Yanagisawa T; Ootubo O; Mimura N
    Transplant Proc; 1996 Jun; 28(3):1220-1. PubMed ID: 8658633
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of the effect of HLA-matched antigens shared between subsequent donors on the second kidney graft outcome.
    Kabakov A; Suslov D; Bubnova L
    Transplant Proc; 1995 Dec; 27(6):3460. PubMed ID: 8540050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.